Composition for heart disease, method to prepare same and uses thereof

Details for Australian Patent Application No. 2003227336 (hide)

International Classifications

Event Publications

14 August 2003 Complete Application Filed

Priority application(s): 10/210,548 31.07.02 US

19 February 2004 Application Open to Public Inspection

Published as AU-B-2003227336

16 December 2004 Application Accepted

Published as AU-B-2003227336

7 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

28 April 2005 Section 223 Application Allowed

Tianjin Tasly Pharmaceutical Co., Ltd., China The time in which to pay the acceptance fee has been extended to 31 Mar 2005. Address for service in Australia - Patent Attorney Services 26 Ellingworth Parade BOX HILL VIC 3128 Extensions of Time, Section 223

5 May 2005 Standard Patent Sealed

6 October 2005 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 26 Aug 2005. Address for service in Australia - Patent Attorney Services 26 Ellingworth Parade BOX HILL VIC 3128

9 August 2012 Application for Amendment

The nature of the amendment is: Amend patentee name to read Tasly Pharmaceutical Group Co., Ltd . Address for service in Australia - Patent Attorney Services 26 Ellingworth Parade Box Hill VIC 3128

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.